🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 1 día
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 12/03/2015 | 0,4294 USD |
| 11/12/2014 | 0,4294 USD |
| 11/09/2014 | 0,4198 USD |
| 12/06/2014 | 0,4198 USD |
| 13/03/2014 | 0,4198 USD |
| 12/12/2013 | 0,4198 USD |
| 12/09/2013 | 0,4103 USD |
| 13/06/2013 | 0,4103 USD |
| 13/03/2013 | 0,4103 USD |
| 13/12/2012 | 0,4103 USD |
| 13/09/2012 | 0,4008 USD |
| 13/06/2012 | 0,4008 USD |
| 13/03/2012 | 0,4008 USD |
| 13/12/2011 | 0,4008 USD |
| 13/09/2011 | 0,3626 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 15/05/1973 | 2,34 | 2,38 | 2,29 | 2,37 | +1,28% | 3,97% | 1.897.718 |
| 14/05/1973 | 2,36 | 2,37 | 2,33 | 2,34 | -0,98% | 1,96% | 1.776.989 |
| 11/05/1973 | 2,41 | 2,41 | 2,36 | 2,36 | -3,26% | 1,93% | 2.124.086 |
| 10/05/1973 | 2,45 | 2,45 | 2,39 | 2,44 | -1,61% | 2,70% | 2.105.222 |
| 09/05/1973 | 2,51 | 2,54 | 2,48 | 2,48 | -1,45% | 2,63% | 882.835 |
| 08/05/1973 | 2,48 | 2,51 | 2,45 | 2,51 | +1,47% | 2,81% | 780.970 |
| 07/05/1973 | 2,51 | 2,51 | 2,47 | 2,48 | -1,58% | 1,58% | 833.789 |
| 04/05/1973 | 2,48 | 2,54 | 2,48 | 2,52 | +1,60% | 2,27% | 1.192.205 |
| 03/05/1973 | 2,47 | 2,48 | 2,39 | 2,48 | +0,54% | 3,76% | 1.316.707 |
| 02/05/1973 | 2,39 | 2,47 | 2,39 | 2,47 | +5,09% | 3,33% | 1.807.171 |
| 01/05/1973 | 2,34 | 2,38 | 2,31 | 2,35 | +0,28% | 2,98% | 811.152 |
| 30/04/1973 | 2,34 | 2,38 | 2,30 | 2,34 | +0,00% | 3,40% | 1.456.301 |
| 27/04/1973 | 2,44 | 2,46 | 2,33 | 2,34 | -4,21% | 5,29% | 1.316.707 |
| 26/04/1973 | 2,45 | 2,45 | 2,42 | 2,44 | -0,94% | 1,35% | 1.079.021 |
| 25/04/1973 | 2,52 | 2,52 | 2,47 | 2,47 | -2,10% | 2,10% | 796.061 |
| 24/04/1973 | 2,58 | 2,58 | 2,52 | 2,52 | -2,57% | 2,44% | 1.580.803 |
| 23/04/1973 | 2,56 | 2,59 | 2,56 | 2,58 | +0,78% | 1,16% | 633.830 |
| 19/04/1973 | 2,54 | 2,56 | 2,53 | 2,56 | +0,91% | 1,43% | 675.331 |
| 18/04/1973 | 2,49 | 2,54 | 2,49 | 2,54 | +1,99% | 1,99% | 339.552 |
| 17/04/1973 | 2,48 | 2,51 | 2,45 | 2,49 | +0,53% | 2,27% | 524.419 |
| 16/04/1973 | 2,51 | 2,52 | 2,45 | 2,48 | -1,32% | 3,17% | 728.150 |
| 13/04/1973 | 2,50 | 2,52 | 2,47 | 2,51 | +0,26% | 2,12% | 980.928 |
| 12/04/1973 | 2,54 | 2,54 | 2,48 | 2,50 | -1,95% | 2,34% | 614.966 |
| 11/04/1973 | 2,57 | 2,57 | 2,52 | 2,55 | -0,51% | 1,67% | 494.237 |
| 10/04/1973 | 2,52 | 2,58 | 2,52 | 2,57 | +2,51% | 2,10% | 1.245.024 |
| 09/04/1973 | 2,49 | 2,51 | 2,49 | 2,50 | +0,67% | 0,93% | 388.598 |
| 06/04/1973 | 2,47 | 2,49 | 2,46 | 2,49 | +0,94% | 1,48% | 777.197 |
| 05/04/1973 | 2,47 | 2,47 | 2,45 | 2,47 | +0,00% | 0,80% | 935.654 |
| 04/04/1973 | 2,43 | 2,48 | 2,43 | 2,47 | +1,36% | 2,18% | 1.007.338 |
| 03/04/1973 | 2,44 | 2,44 | 2,42 | 2,43 | -0,54% | 0,81% | 1.131.840 |